Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 XBP Global XBP Jan 22, 2026 8.00 -1.90   
 Xcel Brands XELB Jan 22, 2026 1.58 +12.86   
 Xcel Energy XEL Jan 22, 2026 75.86 -0.85   
 XCF Global SAFX Jan 22, 2026 0.14 +0.43   
 XChange Tec.Inc ADR XHG Jan 22, 2026 0.88 0.00   
 XCHG Limited - ADS XCH Jan 22, 2026 1.08 -9.24   
 Xencor XNCR Jan 22, 2026 13.11 +0.85   
 Xenetic Biosciences XBIO Jan 22, 2026 2.77 +14.30   
 Xenia Hotels & Resorts XHR Jan 22, 2026 15.29 +0.46   
 Xenon Pharmaceuticals XENE Jan 22, 2026 42.24 +3.02   
 Xeris Biopharma XERS Jan 22, 2026 7.61 -0.13   
 Xerox XRX Jan 22, 2026 2.30 +2.22   
 XIAO-I ADR AIXI Jan 22, 2026 0.29 -9.80   
 Xilio Therapeutics XLO Jan 22, 2026 0.62 +3.40   
 XMAX XWIN Jan 22, 2026 5.79 0.00   
 XOMA XOMA Jan 22, 2026 26.92 -1.28   
 XOMA A Pref XOMAP Jan 22, 2026 26.33 0.00   
 XOMA B Pref XOMAO Jan 22, 2026 25.33 -0.28   
 Xometry A XMTR Jan 22, 2026 62.40 +3.11   
 XORTX Therapeutics XRTX Jan 22, 2026 0.55 -4.01   
 Xos XOS Jan 22, 2026 2.33 +3.56   
 XP A XP Jan 22, 2026 19.83 +3.71   
 XPEL XPEL Jan 22, 2026 54.22 -1.33   
 XPeng A ADR XPEV Jan 22, 2026 19.93 -2.02   
 Xperi XPER Jan 22, 2026 6.21 +1.97   
 XPLR Infrastructure, LP XIFR Jan 22, 2026 9.73 -0.92   
 XPO Logistics XPO Jan 22, 2026 149.60 -0.15   
 Xponential Fitness A XPOF Jan 22, 2026 8.12 +2.27   
 Xtant Medical XTNT Jan 22, 2026 0.62 -1.25   
 XTI Aerospace XTIA Jan 22, 2026 1.88 +5.03   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.